BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:37de98f7-d497-47a7-b70e-3d8672309d6d
DTSTAMP:20250930T210004Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation session
DESCRIPTION:Module - PHA503, Person delivering - Dagan and team
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:038a6efc-8683-4486-a9f7-b599236a7394
DTSTAMP:20250930T210004Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:e4f471e9-aee5-46b7-b1d2-f3feea1e1df5
DTSTAMP:20250930T210004Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:f2490e16-e27e-4a6f-af95-a32a8cea47e9
DTSTAMP:20250930T210004Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:c09f5922-0725-4f4f-85cf-752c8ce5521a
DTSTAMP:20250930T210004Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:43a4a286-c123-4a33-a7a1-915970b87415
DTSTAMP:20250930T210004Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:LT G
END:VEVENT
BEGIN:VEVENT
UID:1aad329a-ed90-4f53-b487-d17340fb06fb
DTSTAMP:20250930T210004Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:7470ecc1-0e15-4e85-b6b4-129a24af8a7d
DTSTAMP:20250930T210004Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:455fe0b2-adf9-4c3a-b637-0f923bd7e1c6
DTSTAMP:20250930T210004Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:afe726d3-296d-4938-979c-6e53642d8b20
DTSTAMP:20250930T210004Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:bdaa4d9e-a7bc-494f-8f8a-ca7fa1d042da
DTSTAMP:20250930T210004Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:9bf7180f-4d66-4bc9-bc6b-db8ea66ec6c6
DTSTAMP:20250930T210004Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:85bf404e-df54-4f29-990e-c01a6893b08b
DTSTAMP:20250930T210004Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:b3114883-d7a9-4151-81a5-3334f503ad65
DTSTAMP:20250930T210004Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:7d992fbd-4554-48cb-8f83-dce9ef76dc36
DTSTAMP:20250930T210004Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:d2ac1d94-ba9e-4c13-a4ff-a6e259a9bd07
DTSTAMP:20250930T210004Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:1a44fbc5-223d-4c30-a04d-e7beccc37136
DTSTAMP:20250930T210004Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:0718ddba-d37d-439c-9eb3-f2a44380d1e9
DTSTAMP:20250930T210004Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:TBC
END:VEVENT
BEGIN:VEVENT
UID:678d392f-c346-4cd8-b692-1cdcb14f9991
DTSTAMP:20250930T210004Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:TBC
END:VEVENT
END:VCALENDAR
